Literature DB >> 3936657

Binding of interleukin 2 to target cells: determination of high and low affinity binding sites on T-lymphoblasts by differential dissociation.

H J Horst, H D Flad.   

Abstract

A new method for the determination of both low and high affinity binding sites on interleukin 2 (IL-2) target cells is described, which is based on differential dissociation of the ligand receptor complex. The technique requires highly purified but not radiolabelled IL-2. In the presence of activated charcoal the low affinity binding sites had a dissociation half time of less than 1 min, while that of the high affinity binding sites was 80 min. Human T-lymphocytes expressed both classes of binding sites within 48 h after PHA stimulation. During culture of PHA-stimulated T-lymphocytes, low affinity binding sites appeared on day 2 and remained high until day 8. High affinity binding sites appeared on day 1, were highest on day 2, and remained high until day 6. The changes in the concentration of the high affinity binding sites are considered as being the result of: receptor stimulation by PHA and/or IL-2 (days 1-2); receptor down regulation by extensive IL-2 production (day 3); increase of unoccupied IL-2 receptor after disappearance of IL-2 from the medium (days 4-6) and cessation of receptor synthesis and receptor breakdown (days 7-10).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936657      PMCID: PMC1577481     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  A method for studying binding proteins, based upon differential dissociation of small ligand.

Authors:  E Milgrom; E E Baulieu
Journal:  Biochim Biophys Acta       Date:  1969-12-23

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  On the mechanism of ligand-induced down-regulation of insulin receptor level in the liver cell.

Authors:  M Krupp; M D Lane
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

Review 5.  Internalization of polypeptide hormones: mechanism, intracellular localization and significance.

Authors:  P Gorden; J L Carpentier; P O Freychet; L Orci
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

6.  Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

Authors:  G D Bonnard; K Yasaka; D Jacobson
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts.

Authors:  P Gorden; J L Carpentier; S Cohen; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Purification of human interleukin 2 to apparent homogeneity and partial characterization of its receptor.

Authors:  R Fagnani; H L Cooper; J Mendelsohn
Journal:  Anal Biochem       Date:  1984-11-01       Impact factor: 3.365

9.  Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  1 in total

1.  Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.

Authors:  H J Horst; H D Flad
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.